The abstract is read at the publisher; the summary is JClub's.
Vitamin D3 attenuates TGF-β1–induced fibrotic gene and protein expression in thyroid eye disease orbital fibroblasts, with VDR knockdown abolishing the anti-fibrotic effect.
- Why it matters: Fibrosis drives restrictive myopathy and disfiguring changes in thyroid eye disease, and TGF-β1 promotes myofibroblast differentiation and ECM deposition; Vitamin D3’s role in this pathway is unclear.
- What they did: Primary orbital fibroblasts from thyroid eye disease patients and normal controls were treated with TGF-β1 (5 ng/mL) ± 1α,25(OH)2D3, measuring CTGF, α-SMA, fibronectin, collagen I, VDR, and Smad2/3 phosphorylation by qRT-PCR, Western blotting, and lentiviral shRNA VDR knockdown.
- The result: Vitamin D3 suppressed TGF-β1–induced pro-fibrotic markers, restored VDR expression reduced in thyroid eye disease, and reduced Smad2/3 phosphorylation; these effects were lost after VDR knockdown, linking the response to VDR-dependent Smad2/3 modulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.